INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (15)
2021
-
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
Nature Communications, Vol. 12, Núm. 1
-
GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 10, pp. 2612-2617
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59
2017
-
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Leukemia Research, Vol. 56, pp. 82-87
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
-
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2016
-
Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes
PLoS ONE, Vol. 11, Núm. 10
2015
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2011
-
A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients
Addictive Behaviors, Vol. 36, Núm. 3, pp. 265-269
-
Estimation of a multiattribute utility function for the Spanish version of the tool questionnaire
Value in Health, Vol. 14, Núm. 4, pp. 564-570
2009
-
Pharmacoeconomic analysis of switching antipsychotic treatment, for inefficiency or adverse effects, to extended-release quetiapine
Pharmacoeconomics - Spanish Research Articles, Vol. 6, Núm. 4, pp. 105-114
2006
-
Neurohormonal blockade in patients with heart failure at discharge from hospital
Anales de Medicina Interna, Vol. 23, Núm. 10
2005
-
A 6-month prospective observational study on the effects of quetiapine on sexual functioning
Journal of Clinical Psychopharmacology, Vol. 25, Núm. 6, pp. 533-538